Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
20 October 2018
Closing Date:
19 November 2018
Location(s):
FR FRANCE
FRM CORSE (FR FRANCE)
FRY RUP FR – RÉGIONS ULTRAPÉRIPHÉRIQUES FRANÇAISES (FR FRANCE)
Description:

Supply of Drugs: Adalimumab biosimilar and various hormones for the institutions of the grouping of orders under the aegis of GCS Uniha - ADALC.

Adalimumab biosimilar 20 mg inj

SL n o 1: SPR inj or eq - quantity is 1 re period: 186.

Adalimumab biosimilar 40 mg inj.

SL n o 1: SPR inj or eq - quantity is 1 re period: 317,

SL n o 2: pen inj or eq - quantity is 1 re period: 1168.

Carbetocin injectable form

SL n o 1: carbetocin injectable form - quantity is 1 re period: 11,477.

Oral misoprostol 25 mcg

SL n o 1: 25 mcg tablets - amount is 1 re period: 4,745.

Download full details as .pdf
The Buyer:
CHU de Bordeaux
CPV Code(s):
33600000 - Pharmaceutical products